Novavax (NVAX) to Present COVID-19 Vaccine Candidate Progress in World Vaccine Congress Webinar Series

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. MRVL
2. ZS
3. STZ
4. PENG
5. NVDA
6. MSFT
7. SPY
8. SKYD
9. APLD
10. LEVI

Go back to Novavax (NVAX) to Present COVID-19 Vaccine Candidate Progress in World Vaccine Congress Webinar Series

Novavax to Present COVID-19 Vaccine Candidate Progress in World Vaccine Congress Webinar Series

May 11, 2020 11:52 AM EDT

GAITHERSBURG, Md., May 11, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that Gregory Glenn, M.D., President of Research and Development, will present progress of NVX-CoV2373, Novavax coronavirus vaccine candidate, on Wednesday, May 13, 2020 as part of the World Vaccine Congress COVID-19 webinar series. Dr. Glenn joins a distinguished group of global public health, epidemiology, regulatory and industry leaders in sharing expertise and information related to the SARS-Cov-2 virus, as well as ongoing efforts to develop vaccines to address the global... More